发明名称 | Indole carboxamide derivatives and uses thereof | ||
摘要 | A compound of Formula (I) is provided that has been shown to be useful for treating a disease, disorder or syndrome that is mediated by the transportation of essential molecules in the mmpL3 pathway:; wherein R1, R2, R3, R4, R5 and R6 are as defined herein. | ||
申请公布号 | US9447039(B2) | 申请公布日期 | 2016.09.20 |
申请号 | US201314420074 | 申请日期 | 2013.09.05 |
申请人 | Novartis AG | 发明人 | Jiricek Jan;Kondreddi Ravinder Reddy;Smith Paul William |
分类号 | C07D209/12;C07D209/42;A61K31/4045;A61K31/407;A61K31/454;A61K31/5377;A61K45/06;C07D491/056 | 主分类号 | C07D209/12 |
代理机构 | Genomics Institute of the Novartis Research Foundation | 代理人 | Smith Chihang Amy;Genomics Institute of the Novartis Research Foundation |
主权项 | 1. A compound of Formula (I)wherein: R1 is H; R2 is H, methyl, trifluoromethyl, chloro, bromo, fluoro, or cyano; R3 is H; R4 is H, methyl, trifluoromethyl, chloro, bromo, fluoro, cyano, or (phenyl)NH—; R5 is H or chloro;provided that R2, R3, R4 and R5 are not all hydrogen; R6 is (C5-C7)cycloalkyl or —CH2-(cyclohexyl), where said (C5-C7)cycloalkyl is optionally substituted with one to two substituents each independently selected from halo, methyl, isopropyl, fluoro-substituted methyl, and ethynyl, provided that R6 is not an unsubstituted cyclohexyl, when R2 and R4 are both methyl; or a pharmaceutically acceptable salt thereof. | ||
地址 | Basel CH |